secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADC Therapeutics SA (ADCT)
CIK:        0001771910
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0000950103-24-006462
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADC Therapeutics raises ~$105M in public offering of common shares and pre-funded warrants
--------------------------------------------------------------------------------

- Offered 13.4M common shares at $4.90/share and pre-funded warrants for 8.2M shares at $4.812/warrant.
- Gross proceeds ~$105M; underwriters include Jefferies, Guggenheim, Cantor Fitzgerald; offering closed May 8, 2024.
- Pre-funded warrants exercisable at CHF 0.08/share, with a 9.99% beneficial ownership cap (adjustable to 19.99%).
- Warrants have a 10-year term and may be exercised on a cashless basis under certain conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771910/000095010324006462/0000950103-24-006462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771910/000095010324006462/dp210968_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-006462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer